CRD007 for the Treatment of Abdominal Aorta Aneurysm (The AORTA Trial)
- Conditions
- Abdominal Aortic Aneurysm
- Interventions
- Drug: CRD007 matching placebo
- Registration Number
- NCT01354184
- Lead Sponsor
- RSPR Pharma AB
- Brief Summary
This is an investigation of the efficacy and safety of CRD007 compared to placebo in the treatment of patients with abdominal aortic aneurysm.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
- Infra-renal abdominal aortic aneurysm
- Previous infra-renal aortic surgery
- Known diabetes
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description CRD007 40 mg tablet CRD007 - CRD007 matching placebo tablet CRD007 matching placebo - CRD007 10 mg tablet CRD007 - CRD007 25 mg tablet CRD007 -
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (15)
Uppsala University Hospital
🇸🇪Uppsala, Sweden
Borås Hospital, Department of Surgery
🇸🇪Borås, Sweden
Mälarsjukhuset, Team Kärl Kir. Klin.
🇸🇪Eskilstuna, Sweden
Centrallaserettet, Kärlkirurgiska Kliniken
🇸🇪Västerås, Sweden
Aarhus Universitetshospital Skejby, Hjerte-Lunge-Kar kir. afd. T
🇩🇰Aarhus, Denmark
Sygehus Lillebælt, Karkirurgisk Forskningsenhed
🇩🇰Kolding, Denmark
Sahlgrenska Universitetssjukhuset
🇸🇪Göteborg, Sweden
Aalborg Hospital, Department of Vascular Surgery V
🇩🇰Aalborg, Denmark
Rigshospitalet, Karkirurgisk afdeling RK 3111
🇩🇰Copenhagen, Denmark
Universitetssjukhuset Örebro, Kirurgkliniken, Kärlsektionen
🇸🇪Orebro, Sweden
Regionshospitalet Viborg, Karkiurgisk Forskningssektion
🇩🇰Viborg, Denmark
Skånes Universitets Sjukhus, Institution of Surgical Science
🇸🇪Malmo, Sweden
Karolinska University Hospital, Kärlkirurgiska Kliniken
🇸🇪Stockholm, Sweden
University Hospital of South Manchester
🇬🇧Manchester, United Kingdom
St George's Hospital NHS Trust
🇬🇧London, United Kingdom